CEO SUMMARY: Elizabeth Holmes, Founder and CEO of Theranos, Inc., was given the ideal platform by AACC to show the science behind her lab companyās much-touted diagnostic technologies. But in a surprise to the assembled audience, Holmes, accompanied by three PhDs on her team, chose to discuss: a) her companyās new business strategy; b) an […]
Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press
Press reaction to the Theranos CEOās speech shows that the company hasnāt much credibility
- By Robert Michel
- > From the Volume XXIII No. 11 - August 15, 2016 Issue
- Tags: aacc, american association of clinical chemistry, analyzer, cap, clia, clia lab, clia requirements, clinical lab, clinical lab scientist, Clinical Laboratory, clinical laboratory scientist, clinical laboratory scientists, clinical laboratory test, clinical laboratory testing, clinical labs, Diagnostic technology, diagnostic testing, disruptive technologies, ehi, Elizabeth Holmes, hematology, lab analyzer, lab assay, lab tech, lab technology, lab test, lab testing, lab tests, laboratories, laboratory medicine, laboratory scientists, laboratory tech, laboratory technician, laboratory technicians, laboratory test, laboratory testing, molecular tests, pathologists, the clinical laboratory, the laboratory, Theranos
